The grant will support the NexTOLL project, which aims to launch a multicentre Phase 2b clinical trial to confirm the neuroprotective effect of ApTOLL in patients with acute ischemic stroke (AIS).
Read more
Los pacientes que recibieron el radiofármaco presentaron mejor tasa de respuesta (43% vs 9%) y una mediana de supervivencia libre de progresión de 22.8 meses frente a 8.5 meses.
Read more
Oncoheroes Biosciences is now at a crucial moment in its quest to find effective therapies for pediatric cancer patients, as they have the unprecedented opportunity to test Volasertib, one of its thre...
Read more
CERTERA's objective is to create a coordinated research and innovation structure to accelerate the preclinical and early stage clinical development of these types of therapies.
Read more
SparingVision today announces a key advancement in its Phase I/II clinical trial for SPVN06, the Company’s lead gene-agnostic investigational gene therapy for the treatment of retinitis pigmentosa (...
Read more
Researchers at the University of Barcelona (UB) are taking part in a consortium working on the research and development of a new drug to treat the cognitive and motor decline associated with the disea...
Read more
Collaboration will support the initiation of a combination arm in the ongoing Phase 1/2a trial in patients with mCRPC
Read more
Researchers at the University of Barcelona are participating in a new consortium to design a drug with an innovative approach against this disease, which could also be used to treat other hereditary r...
Read more
On January 25-26, 2024, in Berlin, Germany, the JOIN4ATMP project held its Kick-off meeting, an initiative created to map, join and drive European activities for Advanced Therapy Medicinal Product (AT...
Read more
El Hospital de Bellvitge supera ya los 100 pacientes tratados de tumores neuroendocrinos con esta terapia personalizada, reforzada por los buenos resultados de los últimos estudios
Read more
It has been developed biocompatible nanoparticles (NPs) that are capable of adsorbing the drug Olaparib (OLA) on their surface, a drug indicated for the treatment of different cancers such as prostate...
Read more
The combined Group, named 3PBIOVIAN, will offer unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substance and Drug Pr...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
